Mei and others reported that the plasma expression of circ-CDYL was significantly different between MCL patients and healthy controls (AUC = 0.856), with no statistically significant difference between circ-CDYL expression levels and prognosis of MCL patients (Mei et al., 2019). The gene discussed is CDYL; the disease is mantle cell lymphoma.